ExesaLibero Pharma is a Morgantown-based research company built around expertise from West Virginia University and partner academic institutions. It develops small-molecule treatments for bone erosion, advancing its lead candidate ELP-004 toward clinical testing for conditions that damage bone and joints.
Financial Conflicts of Interest Policy
Compliance program
FCOI
Quality certification
Modulation TherapeuticsFounded in 2011 as a Moffitt Cancer Research Center spinoff, Modulation Therapeutics is a Morgantown clinical-stage biotechnology company developing therapies for aggressive solid-tumor cancers and liver disease. Its research team combines targeted alpha radiotherapy with peptide and small-molecule drug development, including a therapy for metastatic melanoma that has received FDA Orphan Drug and Fast Track designations. The privately held company moved its primary operations to West Virginia in 2016 and works with West Virginia University researchers to advance its pipeline toward clinical use.MORGANTOWN, WV
Zetagen TherapeuticsFounded in 2015, Zetagen Therapeutics is a private, clinical-stage biopharmaceutical company built around a patient-centered approach to cancer research. From its Colleen Connor Cancer Research Lab, the company develops local treatments for people with metastatic cancer affecting bone, including the investigational therapy ZetaMet, which is designed to address tumors while supporting bone repair.SYRACUSE, NY
Ina Pharmaceutics IncIna Pharmaceutics develops and markets prescription medicines through multi-platform drug-delivery systems, with a portfolio that includes topical corticosteroids and oral therapies. Based in Fairmont, West Virginia, the specialty pharmaceutical company says its product-development and production work follows U.S. Food and Drug Administration current good manufacturing practice regulations.FAIRMONT, WV
EVAX IncEVAX Inc. is the manufacturing and commercialization subsidiary of Enepret Incorporated, a company founded in 2017 to commercialize triterpene-production technologies developed at the University of Kentucky. Its lean team brings together synthetic-biology researchers and pharmaceutical manufacturing specialists to help vaccine developers move from early research into clinical work with non-animal adjuvants and their key ingredients. EVAX manufactures these materials in a 3,500-square-foot facility at the West Virginia University Innovation Corporation in Morgantown.MORGANTOWN, WV